Adherence of Stalevo, Entacapone and Levodopa

Study of Adherence of Stalevo, Entacapone and Levodopa

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00245700

Enrollment

Registered

2005-10-28

Start date

2005-04-30

Completion date

2006-07-31

Last updated

2008-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient. To test if patients with Parkinson's disease who take medicines at regular time intervals have smoother symptom control.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Inclusion criteria

* Patients diagnosed with Parkinson's disease aged between 18 and 85 years fulfilling UK Brain Bank criteria. * Current levodopa therapy prescribed on a regular basis three or more times per day but requiring entacapone because of 'wearing off' * Able to manipulate electronic monitoring bottles and complete questionnaires

Exclusion criteria

* Current use of compliance aid such that study participation would be detrimental to patient's adherence * Pregnancy or breast feeding * Excess alcohol (over 21 units per week for women and 28 units for men) * Mini mental state examination of less than 26. * Severe depression (Geriatric depression score over 20)

Countries

United Kingdom

Outcome results